2010
DOI: 10.1593/neo.91752
|View full text |Cite
|
Sign up to set email alerts
|

Three-dimensional Nuclear Telomere Architecture Is Associated with Differential Time to Progression and Overall Survival in Glioblastoma Patients

Abstract: The absence of biological markers allowing for the assessment of the evolution and prognosis of glioblastoma (GBM) is a major impediment to the clinical management of GBM patients. The observed variability in patients' treatment responses and in outcomes implies biological heterogeneity and the existence of unidentified patient categories. Here, we define for the first time three GBM patient categories with distinct and clinically predictive three-dimensional nuclear-telomeric architecture defined by telomere … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
80
1

Year Published

2010
2010
2018
2018

Publication Types

Select...
6

Relationship

6
0

Authors

Journals

citations
Cited by 49 publications
(86 citation statements)
references
References 31 publications
5
80
1
Order By: Relevance
“…These telomere changes were absent in heterozygous Thrb PV/ + or control mice. Our findings confirm previous reports identifying 3D telomere FISH as an effective diagnostic tool for early detection of individual cancer cells, tumor subtypes, and suitable prognostic indicator of disease progression (24,25,31,62). Recently, we developed an automated 3D telomere scanning procedure capable of rapid imaging of telomere profiles from interphase nuclei, and specific TeloScan software was shown to identify individual tumor cells in large samples (63).…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…These telomere changes were absent in heterozygous Thrb PV/ + or control mice. Our findings confirm previous reports identifying 3D telomere FISH as an effective diagnostic tool for early detection of individual cancer cells, tumor subtypes, and suitable prognostic indicator of disease progression (24,25,31,62). Recently, we developed an automated 3D telomere scanning procedure capable of rapid imaging of telomere profiles from interphase nuclei, and specific TeloScan software was shown to identify individual tumor cells in large samples (63).…”
Section: Discussionsupporting
confidence: 88%
“…We previously showed significant differences in telomeric profiles (i.e., in telomere signal intensity and number, the presence/absence of telomeric aggregates, and in the number of telomeres per nuclear volumes) in therapy-sensitive and therapy-resistant Hodgkin's lymphoma patients (24). These results demonstrated the prognostic value of three-dimensional (3D) telomere diagnostic imaging for glioblastoma patients (25), and suggested a 3D telomere dysfunction-based progression model leading to the progression of myelodysplastic syndromes to acute myeloid leukemias (26).…”
Section: Trb1mentioning
confidence: 71%
“…We anticipate the use of this scanning technology in the detection of rare cancer cells, in the screening of risk groups, and in the assessment of treatment success. Moreover, it has already shown to have the ability of sub-classifying patient subgroups that could not previously be identified (11). We also expect its success in guiding patient treatment decisions based on the recognition of recurrent/aggressive telomere profiles observed at diagnosis (40).…”
Section: Discussionmentioning
confidence: 94%
“…Telomere measurements were performed using TeloView for the manual 3D-acquisition (35,38), TeloScan for the automated 3D-acquisition (11). The integrated intensity of each telomere was calculated based on the linear correlation between telomere length and signal intensity.…”
Section: D Image Analysis For Telomeresmentioning
confidence: 99%
See 1 more Smart Citation